A61K 31/60
Salicylic acid
Official title: Salicylic acid; Derivatives thereof
A61K31/60 (Salicylic acid) appears on 2,290 US grants and 3,526 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,290
- Published applications
- 3,526
- Assignees
- 1,616
- Inventors
- 5,773
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 17 | 0 |
| 1977 | 19 | 0 |
| 1978 | 19 | 0 |
| 1979 | 8 | 0 |
| 1980 | 11 | 0 |
| 1981 | 12 | 0 |
| 1982 | 13 | 0 |
| 1983 | 7 | 0 |
| 1984 | 17 | 0 |
| 1985 | 22 | 0 |
| 1986 | 14 | 0 |
| 1987 | 18 | 0 |
| 1988 | 23 | 0 |
| 1989 | 21 | 0 |
| 1990 | 23 | 0 |
| 1991 | 24 | 0 |
| 1992 | 19 | 0 |
| 1993 | 16 | 0 |
| 1994 | 9 | 0 |
| 1995 | 17 | 0 |
| 1996 | 15 | 0 |
| 1997 | 54 | 0 |
| 1998 | 63 | 0 |
| 1999 | 79 | 0 |
| 2000 | 51 | 0 |
| 2001 | 38 | 16 |
| 2002 | 38 | 54 |
| 2003 | 36 | 82 |
| 2004 | 26 | 90 |
| 2005 | 20 | 96 |
| 2006 | 23 | 112 |
| 2007 | 23 | 109 |
| 2008 | 21 | 81 |
| 2009 | 19 | 109 |
| 2010 | 39 | 144 |
| 2011 | 34 | 110 |
| 2012 | 51 | 128 |
| 2013 | 83 | 167 |
| 2014 | 106 | 197 |
| 2015 | 109 | 201 |
| 2016 | 110 | 213 |
| 2017 | 133 | 194 |
| 2018 | 117 | 182 |
| 2019 | 110 | 180 |
| 2020 | 116 | 180 |
| 2021 | 99 | 178 |
| 2022 | 72 | 177 |
| 2023 | 88 | 170 |
| 2024 | 71 | 132 |
| 2025 | 76 | 132 |
| 2026 | 41 | 92 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Piperidine urea derivatives for cancer therapy15 Sep 2026US 12,734,164 B2NeuroPn Therapeutics, Inc.
- Delayed release oral pharmaceutical composition8 Sep 2026US 12,728,097 B2Aihol Corporation
- Topical preparations18 Aug 2026US 12,708,645 B2Epitheal Limited
- Methods of treating hepatic encephalopathy4 Aug 2026US 12,697,326 B2Salix Pharmaceuticals, Inc.
- Stable compositions of functional ingredients and methods of making the same28 Jul 2026US 12,691,078 B2Nulixir Inc.
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Pharmaceutical composition comprising anacardic acid used for cell-based coagulation8 Oct 2026US 2026/0306513 A1
- Sensor for analyte monitoring with drug-eluting capabilities1 Oct 2026US 2026/0294292 A1Senseonics, Incorporated
- Methods for treating gastrointestinal inflammatory diseases using alpha-ketoglutarate (akg) modulators1 Oct 2026US 2026/0294856 A1
- Systems and methods for delivery of drugs and other substances comprising deep eutectic solvents24 Sep 2026US 2026/0283948 A1Novilla Pharmaceuticals, Inc.
Most cited
By later US patents
- Method for treating infectious respiratory diseases270US 5,290,540 AThe Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. · 1994
- Enteral pharmaceutical compositions266US 4,070,494 ABayer Aktiengesellschaft · 1978
- Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth243US 6,861,053 B1Cedars-Sinai Medical Center · 2005
- Opioid agonist/antagonist combinations238US 6,696,066 B2Euro-Celtique S. A. · 2004
- Opioid agonist/antagonist combinations235US 6,277,384 B1Euro-Celtique S.A. · 2001